Delivery Order SPE2DE21D0017-SPE2D626F4172
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $1,800.00 on September 23, 2025, for the supply of Alere ID NOW Flu A and B2 Qualified Detector Virus kits. The contract is a fixed-price delivery order with economic price adjustment provisions and will be performed in Lockhart, Florida, with an ultimate completion date of September 30, 2025. The award was made without a set-aside designation, indicating open competition. The...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a $1,200 fixed-price delivery order with economic price adjustment from the Defense Logistics Agency Medical Supply Chain on April 28, 2025, for ID NOW flu diagnostic tests. The contract, awarded without set-aside designation through open competition, is designated as delivery order 4568059894 and carries an ultimate completion date of May 5, 2025. Performance will be executed at the contractor's location in...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $15,000 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency (DLA) Medical Supply Chain on August 7, 2025, for ID NOW flu diagnostic testing products. The contract, which carries no set-aside designation, indicates open competition and is scheduled for ultimate completion on August 14, 2025. Performance will occur at the vendor's location in Lockhart, Florida. This...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $10,200 delivery order on July 24, 2025, for ID NOW flu tests under contract 4568885102. This fixed-price delivery order with economic price adjustment has an ultimate completion date of July 31, 2025, and will be performed in Lockhart, Florida. The award was made without a set-aside designation, indicating open competition. The funding agency is the Defense Logistics Agency (DLA) Medical Supply Chain,...
- This is a delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain unit to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide the ID NOW FLU testing system. The $43,200.00 fixed-price contract with economic price adjustment has an ultimate completion date of October 31, 2024. The award does not have a set-aside designation. Abbott Rapid DX North America LLC, doing business as Alere North America LLC, is a major supplier of COVID-19...
- This is a federal contract award from the Defense Logistics Agency (DLA) Medical Supply Chain to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The $2,208.00 fixed-price with economic price adjustment delivery order is for the ID NOW FLU product, which is a medical diagnostic testing device. The contract has an ultimate completion date of May 2, 2025 and was awarded on April 25, 2025. This award is not associated with a set-aside designation. Abbott Rapid DX North...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $3,624.00 fixed-price delivery order with economic price adjustment on September 18, 2025, for an ID NOW point-of-care clinical analyzer. The contract is scheduled for completion by September 22, 2025, and will be performed in Lockhart, Florida. The award was made without a set-aside designation, indicating open competition. Funding is provided by the Defense Logistics Agency Medical Supply Chain, a...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $2,400.00 delivery order by the Defense Logistics Agency Medical Supply Chain on October 23, 2025, for COVID-19 virus test kits (KIT ID NOW COVID-19 VIR TST 24 TST). The contract utilizes fixed-price pricing with economic price adjustment provisions and is scheduled for completion by October 31, 2025. Performance will be conducted at the company's location in Lockhart, Florida. This delivery order was...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories specializing in medical diagnostics, was awarded a $6,000 fixed-price delivery order for ID NOW COVID-19 virus test kits by the Defense Logistics Agency Medical Supply Chain on September 11, 2025. The delivery order, which has no set-aside designation, indicates open competition and carries an ultimate completion date of September 19, 2025. The performance location is identified as Lockhart, Florida. This award represents a...
- This federal contract award, with ID SPE2DE21D0017|SPE2D624F6X4T, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The $43,200.00 fixed-price with economic price adjustment delivery order is for the supply of 4564728806 ID NOW FLU diagnostic products, without any set-aside designation. Abbott Rapid DX North America LLC, doing business as Alere North America LLC, is a major supplier...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D626F4172Delivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on October 23, 2025, valued at $2,400 for Alere ID NOW Flu A/B Qualification Detection Virus kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is set to be completed by October 29, 2025. The funding agency is the Defense Logistics Agency Medical Supply Chain, a defense-affiliated entity responsible for sourcing medical supplies and equipment across federal healthcare systems. The place of performance is located in Lockhart, Florida, where Abbott Rapid DX maintains its principal operations for diagnostic testing products. This delivery order represents a continuation of Abbott's established role as a critical supplier of point-of-care diagnostic testing solutions to federal defense and healthcare agencies. The ID NOW platform is a molecular diagnostic system widely utilized across the Department of Defense and Department of Veterans Affairs for rapid detection of influenza and other respiratory pathogens, supporting medical readiness and public health initiatives. No set-aside designation was applied to this award, reflecting Abbott's competitive positioning in full and open procurement. The company maintains an extensive portfolio of indefinite delivery vehicles and blanket purchase agreements across multiple Veterans Integrated Service Networks and the Defense Health Agency, demonstrating sustained federal procurement relationships valued in the tens of millions of dollars for diagnostic equipment and consumables.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 10/23/25 |